Hepatitis C virus genetics affects miR-122 requirements and response to miR-122 inhibitors
Benjamin Israelow(Yale University), Matthew J. Evans(Icahn School of Medicine at Mount Sinai), Marion Sourisseau(Icahn School of Medicine at Mount Sinai), Andres Y. Maldonado(Icahn School of Medicine at Mount Sinai), Arvin C. Dar(Memorial Sloan Kettering Cancer Center), Gavriel Mullokandov(Icahn School of Medicine at Mount Sinai), Judith Agudo(Harvard University), Brian D. Brown(Icahn School of Medicine at Mount Sinai), Ali Bashir(Icahn School of Medicine at Mount Sinai)
Cited by 72